Detalhe da pesquisa
1.
BERTMHC: improved MHC-peptide class II interaction prediction with transformer and multiple instance learning.
Bioinformatics
; 37(22): 4172-4179, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096999
2.
Roflumilast-induced Local Vascular Injury Is Associated with a Coordinated Proteome and Microparticle Change in the Systemic Circulation in Pigs.
Toxicol Pathol
; 43(4): 569-80, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311372
3.
Translation strategy for the qualification of drug-induced vascular injury biomarkers.
Toxicol Pathol
; 42(4): 658-71, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24771082
4.
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
Eur J Cancer
; 191: 112981, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37506588
5.
Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients.
Cancers (Basel)
; 14(9)2022 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565310
6.
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361728
7.
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.
Clin Transl Immunology
; 11(5): e1392, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35573979
8.
Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients.
Cancer Immunol Res
; 10(6): 745-756, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439304
9.
Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC.
Front Oncol
; 10: 591063, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33575210
10.
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial.
Hum Vaccin Immunother
; 16(2): 388-399, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31373537
11.
Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-ßGal and MVA-MUC1 (TG4010) in a murine tumor model.
Hum Vaccin Immunother
; 14(1): 140-145, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28925793
12.
Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.
Hum Vaccin Immunother
; 13(9): 1997-2003, 2017 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28846477
13.
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC.
J Immunother Cancer
; 5(1): 70, 2017 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923084
14.
A generic operational strategy to qualify translational safety biomarkers.
Drug Discov Today
; 16(13-14): 600-8, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21570476